Dr. Jin-Hyeon Jeong is currently an industry-academic professor at Seoul National University's Siheung Campus, the president of the PDA (Parenteral Drug Association, an international GMP organization) Korea Chapter, and the CEO of AbChemBio, which develops ADCs (antibody-drug conjugates).

Dr. Jeong graduated from Department of Pharmaceutical Sciences, Seoul National University and received a Doctor of Science from Department of Chemistry, Stanford University, followed by a post-doc for 3 years at the Scripps Research Institute in USA. Then, he worked as an appointed senior researcher at Department of Applied Chemistry of KIST, and served as a professor at College of Pharmacy, Kyung Hee University for 14 years. Afterwards, he served as a professor at College of Pharmacy, Yonsei University for 11 years. During that period, he served as the head of Biopharmaceutical Industry Graduate Program for 5 years and received the 2018 Korea Pharmaceutical Industry Award for Excellence from the government. 

He planned K-NIBRT, a biopharmaceutical training center and developed hands-on training courses such as mRNA vaccines manufacturing as the founding director of the training center. Currently, he plans a WHO-designated global bio-campus education center at Seoul National University which includes cell and gene therapy process training and biopharma 4.0 training.